About Us: Partnership Opportunities

With our proprietary approach, Allarity Therapeutics is at the forefront of cancer precision medicine development.

Our DRP® platform is able to unlock the complexity of a tumor and provide a best-in-class companion diagnostic to match the right patient to the right cancer drug.
Allarity Therapeutics seeks partnering opportunities in the following areas:
  • Co-development and co-funding of Phase 2 and Phase 3 clinical trials
  • Creation of joint ventures to advance programs of mutual interest
  • Regional or global drug development and marketing programs
  • DRP® companion diagnostic development for external drug program

Interested in partnering opportunities with Allarity? Contact us at

Sign up for press releases

Sign up for press releases and receive relevant information about Allarity Therapeutics A/S.